Profile cover photo
Profile photo
Kyle Ramer
4 followers
4 followers
About
Kyle's posts

Post has attachment
Photo

Post has attachment
iCo Therapeutics Inc: Conference & Catalyst
Summary Phase 2 trial for the treatment of diabetic macular edema (DME). ICo-007 Potential advantages, insight from a M.D. PhD, Medicine, Immunology. Conference Preview ( OTCQX:ICOTF ). IDEAL Study: A Randomized, Multi-center, Phase II Study of the safety, ...

Post has attachment
Inovio (INO) new abstract tuesday march 25th
Click link here to INO abstract Co-administration of Molecular adjuvants

Post has attachment
Inovio (INO) New Interview with Dr. Kim about Inovio's research and treatment for cancer.
Money Matters 14-11 Hosts :   David Ebner of Merrill Lynch & Charlie Shields of Wells Fargo Advisors, LLC Guests :   J. Joseph Kim, Ph. D., CEO, of Inovio Pharmaceuticals Description :   Dave & Charlie talk about investing and then interview Dr. Kim about I...

Post has attachment
Inovio (INO) New Interview with Dr. Kim about Inovio's research and treatment for cancer.
Money Matters 14-11 Hosts :   David Ebner of Merrill Lynch & Charlie Shields of Wells Fargo Advisors, LLC Guests :   J. Joseph Kim, Ph. D., CEO, of Inovio Pharmaceuticals Description :   Dave & Charlie talk about investing and then interview Dr. Kim about I...

Post has attachment
INOVIO (INO) CANCER ANTIBODIES CONFERENCE
CANCER ANTIBODIES VACCINES/ADJUVANTS & DELIVERY 17-19 September 2014, Switzerland (INOVIO will co-sponsor this conference) "This CAVAD 2014 conference brings together  experts in both fields of mabs and vaccines to address these important issues. CAVAD 2014...

Post has attachment
OncoSec (ONCS)June 26-27th, 2014 4th European Post Chicago Melanoma/ Skin Cancer Meeting
Results and Interpretations of ASCO presentations 2014  (Global confernce on news in melanoma/skin cancer)  Friday, June 27th 2014 Session- New drugs and trials: An update on immunotherapy and chemotherapy  9:36- Electroporation (Adil I. Daud) In addition P...

Post has attachment
Inovio (INO) March 2014 Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine
Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine  [Epub ahead of print] Jian Yan a ,  Daniel O. Villarreal b ,  Trina Racine c ,  Jaemi S. Chu b ,  Jewell N. Walters b ,  Matthew P. Morrow a , Amir S. Khan a ,  Niranjan Y. Sar...

Post has attachment
OncoSec Medical (ONCS) May 21-24, 2014 ASGCT 17th Annual Meeting
Scientific  Symposium 213 Thursday May 22, 2014 Richard Heller, PHD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase 1 and 2 Trials Electrotransfer of plasmids encoding cytokines directly to tumors has been shown to genera...

Post has attachment
OncoSec Medical (ONCS) May 21-24, 2014 ASGCT 17th Annual Meeting
Thursday, May 22nd, 2014 Richard Heller, PhD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase I and II Clinical Trials Electrotransfer of plasmids encoding cytokines directly to tumors has been shown to generate a local an...
Wait while more posts are being loaded